Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CODX Co-Diagnostics, Inc. Common Stock
$2.72 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CODX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 4.9M
Enterprise value -5144284
Trailing PE -0.063924731746797
Forward PE -0.1975307
PEG Ratio -4.5660522676283E-5
Enterprise to EBITDA 0.15
Enterprise to revenue -10.129
Price to book MRQ 0.09670011
Price to sales TTM 9.899888

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 507.9K
EBITDA -34334228
Diluted EPS TTM -25.68
Total Cash (MRQ) 11.4M
Current ratio (MRQ) 3.806
Operating Cash Flow (TTM) -31168636

CODX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CODX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.